Lionsgate Studios Corp Common Shares (LION)

Fundamentals

1-day range

$12.83$13.4

Market cap

$3.85B

P/E (trailing)

—

P/E (forward)

30.88

EPS (trailing)

—

Dividend yield

—

Beta

—

Avg. volume

3.39M

Forecasts

10 analyst ratings

Lionsgate Studios Corp Common Shares Competitors

Chosen by industry and closest market cap.

• LION

  Lionsgate Studios Corp Common Shares

  $11.4

  ▼ 1.21%
  Market cap $3.85BP/E —
  $5.88$16.7
• FUBO

  FuboTV Inc. Class A Common Stock

  $10.29

  ▲ 1.88%
  Market cap $974.84MP/E 2.41
  $7.95$56.64
• MCS

  Marcus Corporation (The) Common Stock

  $28.99

  ▼ 1.23%
  Market cap $944.39MP/E 39.66
  $12.85$32.42
• CURI

  CuriosityStream Inc. Class A Common Stock

  $2.62

  ▲ 2.34%
  Market cap $158.89MP/E —
  $2.3$5.51
• RDI

  Reading International Inc Class A Common Stock

  $2.01

  ▼ 3.60%
  Market cap $35.21MP/E —
  $0.935$2.11
• TOON

  Kartoon Studios Inc. Common Stock

  $0.6569

  ▲ 2.32%
  Market cap $35.05MP/E 8.00
  $0.5036$1.29

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Reported Earlier: "Lionsgate Faces Activist Pressure To Sell Itself In 'AI Era'" - Semafor
  Benzinga · 8/11/2026
• B. Riley Securities Maintains Neutral on Lionsgate Studios, Lowers Price Target to $16
  Benzinga · 8/10/2026
• Lionsgate Is Off To A Strong Start, Might Not Finish The Year Independent
  SeekingAlpha · 8/10/2026
• Starz Entertainment's Stock Is Powerful, But It Still Rates As A Hold
  SeekingAlpha · 8/10/2026
• Lionsgate Studios Corp. (LION) Q1 2027 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Lionsgate Studios (NYSE:LION) Rises 4.3% After Q1 Revenue and Adjusted EPS Beat Estimates
  ChartMill · 8/7/2026
• Lionsgate Studios Q1 Adj. EPS $0.06 Beats $(0.00) Estimate, Sales $776.600M Beat $698.830M Estimate
  Benzinga · 8/6/2026

• Mark H. Rachesky, MD · July 8, 2026 · Buy

  11.76M
• Mark H. Rachesky, MD · July 8, 2026 · Sale

  11.76M
• Mark H. Rachesky, MD · July 8, 2026 · Buy

  15.80M
• Mark H. Rachesky, MD · July 8, 2026 · Buy

  499.8K
• Mark H. Rachesky, MD · July 8, 2026 · Sale

  499.8K
• Mark H. Rachesky, MD · July 8, 2026 · Buy

  671.9K
• Mark H. Rachesky, MD · July 8, 2026 · Buy

  11.15M
• Mark H. Rachesky, MD · July 8, 2026 · Buy

  1.92M
• Mark H. Rachesky, MD · July 8, 2026 · Buy

  797.5K
• Mark H. Rachesky, MD · July 8, 2026 · Sale

  25.17M
• Mark H. Rachesky, MD · July 8, 2026 · Sale

  3.70M
• Mark H. Rachesky, MD · July 8, 2026 · Sale

  1.47M
• Jon Feltheimer · July 3, 2026 · Tax Withholding

  103.7K @ $14.66
• Jon Feltheimer · July 3, 2026 · Grant

  196.9K
• Bruce Tobey · July 3, 2026 · Tax Withholding

  10.0K @ $14.66

Institutional Ownership

March 31, 2026

Total shares held

255.98M

Total value held

$2.40B

Institutional holders

268